Roopal Thakkar in

Roopal Thakkar

Login to view DISC.
Executive Vice President, Research & Development and Chief Scientific Officer at AbbVie
📍 North Chicago, Illinois, United States

As Executive Vice President and Chief Scientific Officer at AbbVie, Roopal Thakkar leads a global team of over 14, 000 in research and development. A physician by training with an M. D. from Wayne State University, he is focused on advancing AbbVies pipeline across immunology, oncology, and neuroscience to turn molecules into life-changing medicines for patients.

Roopal is an advocate for diversity and inclusion within his organization. He has actively participated in employee resource groups, such as the Asian Leadership Network, to foster conversations about culture, leadership, and the importance of finding ones voice in a corporate environment.

He recently spearheaded AbbVies first FDA approval in lung cancer, a significant milestone for the companys antibody-drug conjugate (ADC) portfolio.

Read the full overview →
Experience
10 Years
Current Role
Executive Vice President, Research & Development and Chief Scientific Officer
Job Level
Leadership
Location
North Chicago, Illinois, United States
Personality Overview

How Roopal shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Roopal cares about

Oncology Innovation
Leads the development of AbbVie's antibody-drug conjugate (ADC) portfolio, including a recently approved therapy for non-small cell lung cancer.
Neuroscience R&D
Focuses on addressing challenges in psychiatric and neurological disorders, including Alzheimer's, through strategic partnerships and acquisitions.
+5 more topics Login to view topics
Career

Work history

7-2024
Executive Vice President, Research & Development and Chief Scientific Officer
AbbVie
12-2023 - 7-2024
Senior Vice President, Global Therapeutics and Chief Medical Officer
AbbVie
12-2022 - 12-2023
Senior Vice President, Development and Regulatory Affairs and Chief Medical Officer
AbbVie
6-2010 - 6-2012
Project Director
Abbott Laboratories
5-2009 - 5-2010
Project Director
Abbott Laboratories
In the press

Media appearances

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer. Featured in PRNewswire
See now
AbbVie Appoints Executive Vice President, Research Development and Chief Scientific Officer. Featured in American Pharmaceutical Review
+5 more appearances Login to view media
Education
1994 - 1998
MD
Wayne State University School of Medicine
1990 - 1993
BS
University of Michigan
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other AbbVie Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Roopal. Free, 10 seconds.